Researchers at Politecnico di Torino have developed new energy storage technology that could help tackle two major global challenges: reducing industrial carbon emissions and boosting renewable energy efficiency.
The European Commission has allocated €14 billion to nine Member States under the Support to mitigate Unemployment Risks in an Emergency (SURE) programme.
David John, CEO and Founder of Loyalize, discusses why the Government needs to ensure that data is at the heart of its retail bounce back education strategy.
AstraZeneca dose efficiency holds at 76% in the three-month period between the first and second dose - suggesting that this time period is good for maximising protection.
Jade Brooks, an associate solicitor at Blaser Mills Law, responds to The Supreme Court’s ruling on coronavirus-related business interruption insurance claims and discusses what it means for policyholders.
Childhood air pollution has been understood as partially responsible for respiratory health - now, researchers are investigating at how exposure can damage cognitive ability later on in life.
Eunomia is calling on the UK government to consider a What Works Centre for the environment to share evidence on what works best when it comes to environmental policymaking – Consultant Alexa Cancio and Head of Evaluation Joe Hudson explains why.
The impact of climate change in South Africa can be seen in economic productivity, healthcare outcomes and labour availability - but what could it cost the population in the future, if left unchecked?
According to data collected by 400 healthcare professionals at the worst moment of the US outbreak, the life support machine that acts in place of the heart and lungs is crucial to reducing COVID-19 deaths for the critically ill.
An STFC-funded project, MoleGazer, has successfully implemented astronomical techniques, used for star-gazing, to detect and track the evolution of cancerous moles.
The American Heart Association found that young, Black adults are more than twice as likely to die in the first year after a heart transplant - in comparison to non-Black transplant recipients of the same age.
The vaccine roll out gives hope of a return to some form of normality, but current high COVID-19 infection numbers put the success of vaccination programmes at risk. Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences explain why.
